Velocity Advisory Group, a leading provider ofleadership development, cultural assessments, and advisory services today announced the appointment of Brooke Page-Thompson as the firm’s next President. With over 20 years of experience working with Fortune 500 companies to support large-scale transformation, Brooke has been an integral part of Velocity’s growth since joining the firm in 2020 […]

Data underscore the potential to leverage comprehensive epigenomic profiling from a simple blood test to explore central nervous system disease biology BOSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) — Precede Biosciences, a company impacting the development and use of precision medicines with a first-in-class comprehensive epigenomic liquid biopsy platform, today shared the company’s scientific poster presentation

Direct private lender steps in and quickly closes the deal when the project’s initial lender backed out at the last minute A new mixed-use development is coming to one of the fastest-growing regions in the United States, with help from Kennedy Funding. https://mma.prnewswire.com/media/1631473/Kennedy_Funding_Logo.jpg The Englewood, New Jersey-based direct private lender announced today the closing of

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Verve Therapeutics, Inc. ("Verve" or the "Company") (NASDAQ:VERV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form?prid=103839&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Vicor Corporation (NASDAQ:VICR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/vicor-corporation-lawsuit-submission-form?prid=103838&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Spire Global, Inc. (NYSE:SPIR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/spire-global-inc-lawsuit-submission-form?prid=103837&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Methode Electronics, Inc.. ("Methode" or the "Company") (NYSE:MEI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Endava plc ("Endava" or the "Company") (NYSE:DAVA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Methode Electronics, Inc. (NYSE:MEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/methode-electronics-inc-lawsuit-submission-form?prid=103836&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call